Fox, S., Generali, D., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Harris, A. (2011). The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিFox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিFox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.